- Mar 22, 2012
The FDA is apparently going to review the existing data It is far from a sure thing but hopeful indeed. Advocacy matters and if it gets approved credit to all but especially Brian Wallach and wife Sandra
Amylyx Pharmaceuticals Announces Plan to Submit New Drug Application (NDA) for AMX0035 for the Treatment of ALS in the Coming Months
Amylyx today announced its intention to submit a New Drug Application (NDA) to the U.S. FDA for AMX0035 for the treatment of ALS.
The decision to review an experimental treatment for amyotrophic lateral sclerosis based on a single study follows pressure from activists.